PACK IN HAND · ONE-PAGE CHECK
Medicine pack check sheet
Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.
Published record starting point
- Record display name
- Xarelto
- Generic name / active ingredient
- rivaroxaban
- Dosage-form class
- Dosage form and presentation as documented in the linked primary label
- Route
- Oral
- Record reviewed
- 2026-08-24
Copy from the pack in hand
Source-linked reading points
- Check XARELTO, the generic name rivaroxaban, per-tablet strength, oral-tablet form, NDC, package count and target market together. The 2.5 mg/60-tablet bottle and the 10 mg, 15 mg and 20 mg/30-tablet bottles are distinct label identities; none of these numbers establishes a person's condition, course, daily use or interchangeability with another medicine.
- Anticoagulant-related medicines must not be self-switched, combined, made up after a missed dose or temporarily stopped merely because they are all described as preventing clots. For a switch, missed use, symptoms or a procedure, contact the prescribing team or pharmacist with the complete medicine list.
- Anti-inflammatory pain medicines, antiplatelet or other clotting-related products, and any newly added prescription, OTC, supplement or herb all need joint review. Do not treat one interaction note on a webpage as an instruction to start or stop any medicine.
- Appearance and label images serve source checking only. Strength, market, packaging form and label version can differ; an image cannot authenticate a product, confirm a current label or replace clinical instructions around bleeding or procedures.
Reviewed presentation examples — compare every field
- 2.5 mg per tablet; 60-tablet bottleNDC 50458-577-60
- 10 mg per tablet; 30-tablet bottleNDC 50458-580-30
- 15 mg per tablet; 30-tablet bottleNDC 50458-578-30
- 20 mg per tablet; 30-tablet bottleNDC 50458-579-30